Corline Biomedical AB banner
C

Corline Biomedical AB
STO:CLBIO

Watchlist Manager
Corline Biomedical AB
STO:CLBIO
Watchlist
Price: 15.35 SEK 1.66%
Market Cap: kr393.1m

Corline Biomedical AB
Investor Relations

Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-06-03. The company develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.

Show more
Loading
CLBIO
OMX Stockholm 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Henrik Nittmar Ph.D.
Chief Executive Officer
No Bio Available
Ms. Asa Holm
Chief Operating Officer
No Bio Available

Contacts

Address
UPPSALA
Uppsala
Lefflersgatan 5
Contacts
+461871346946
www.corline.se
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett